(19)
(11) EP 4 824 284 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24827815.2

(22) Date of filing: 11.12.2024
(51) International Patent Classification (IPC): 
C12Q 1/6883(2018.01)
 A61K 31/165(2006.01)
(52) Cooperative Patent Classification (CPC):
C12Q 1/6883; C12Q 2600/106; C12Q 2600/136; C12Q 2600/156
(86) International application number:
PCT/EP2024/085681
(87) International publication number:
WO 2025/125328 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 11.12.2023 EP 23215557
02.12.2024 EP 24216797

(71) Applicant: Universiteit Antwerpen
2000 Antwerpen (BE)

(72) Inventors:
  • TIMMERMAN, Vincent
    2020 Antwerpen (BE)
  • SISTO, Angela
    2020 Antwerpen (BE)

(74) Representative: De Clercq & Partners 
Edgard Gevaertdreef 10a
9830 Sint-Martens-Latem
9830 Sint-Martens-Latem (BE)

   


(54) THERAPEUTIC AGENTS FOR USE IN THE TREATMENT AND PREVENTION OF NEUROPATHY, MYOPATHY OR CARDIO(MYO)PATHY